These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1117 related articles for article (PubMed ID: 34375189)

  • 1. The use of Pseudotyped Coronaviruses for the Screening of Entry Inhibitors: Green Tea Extract Inhibits the Entry of SARS-CoV-1, MERSCoV, and SARS-CoV-2 by Blocking Receptor-spike Interaction.
    Joseph J; Karthika T; Das VRA; Raj VS
    Curr Pharm Biotechnol; 2022; 23(8):1118-1129. PubMed ID: 34375189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening of Natural Products Inhibitors of SARS-CoV-2 Entry.
    González-Maldonado P; Alvarenga N; Burgos-Edwards A; Flores-Giubi ME; Barúa JE; Romero-Rodríguez MC; Soto-Rifo R; Valiente-Echeverría F; Langjahr P; Cantero-González G; Sotelo PH
    Molecules; 2022 Mar; 27(5):. PubMed ID: 35268843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of Neutralizing Antibodies in Serum Samples Using a SARS-CoV-2 Pseudotyped Virus Assay.
    Ferrero S; Batto MV; Gatto MI; Dimase F; Helguera G
    Curr Protoc; 2024 Oct; 4(10):e70025. PubMed ID: 39373132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Middle East respiratory syndrome coronavirus infection is inhibited by griffithsin.
    Millet JK; Séron K; Labitt RN; Danneels A; Palmer KE; Whittaker GR; Dubuisson J; Belouzard S
    Antiviral Res; 2016 Sep; 133():1-8. PubMed ID: 27424494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mulberry Component Kuwanon C Exerts Potent Therapeutic Efficacy In Vitro against COVID-19 by Blocking the SARS-CoV-2 Spike S1 RBD:ACE2 Receptor Interaction.
    Kim YS; Kwon EB; Kim B; Chung HS; Choi G; Kim YH; Choi JG
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants.
    Tai W; Wang Y; Fett CA; Zhao G; Li F; Perlman S; Jiang S; Zhou Y; Du L
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 Cellular Entry Is Independent of the ACE2 Cytoplasmic Domain Signaling.
    Karthika T; Joseph J; Das VRA; Nair N; Charulekha P; Roji MD; Raj VS
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and evaluation of the inhibitory effect of Prunella vulgaris extract on SARS-coronavirus 2 virus entry.
    Ao Z; Chan M; Ouyang MJ; Olukitibi TA; Mahmoudi M; Kobasa D; Yao X
    PLoS One; 2021; 16(6):e0251649. PubMed ID: 34106944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 Is an Important Surface Attachment Factor That Facilitates Entry of Middle East Respiratory Syndrome Coronavirus.
    Chan CM; Chu H; Wang Y; Wong BH; Zhao X; Zhou J; Yang D; Leung SP; Chan JF; Yeung ML; Yan J; Lu G; Gao GF; Yuen KY
    J Virol; 2016 Oct; 90(20):9114-27. PubMed ID: 27489282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies constructed from COVID-19 convalescent memory B cells exhibit potent binding activity to MERS-CoV spike S2 subunit and other human coronaviruses.
    Peng Y; Liu Y; Hu Y; Chang F; Wu Q; Yang J; Chen J; Teng S; Zhang J; He R; Wei Y; Bostina M; Luo T; Liu W; Qu X; Li YP
    Front Immunol; 2022; 13():1056272. PubMed ID: 36618428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Close relatives of MERS-CoV in bats use ACE2 as their functional receptors.
    Xiong Q; Cao L; Ma C; Tortorici MA; Liu C; Si J; Liu P; Gu M; Walls AC; Wang C; Shi L; Tong F; Huang M; Li J; Zhao C; Shen C; Chen Y; Zhao H; Lan K; Corti D; Veesler D; Wang X; Yan H
    Nature; 2022 Dec; 612(7941):748-757. PubMed ID: 36477529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human ACE2 Genetic Polymorphism Affecting SARS-CoV and SARS-CoV-2 Entry into Cells.
    Hattori T; Saito T; Okuya K; Takahashi Y; Miyamoto H; Kajihara M; Igarashi M; Takada A
    Microbiol Spectr; 2022 Aug; 10(4):e0087022. PubMed ID: 35862965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the Role of N-Linked Glycosylation in Cell Surface Expression, Function, and Binding Properties of SARS-CoV-2 Receptor ACE2.
    Rowland R; Brandariz-Nuñez A
    Microbiol Spectr; 2021 Oct; 9(2):e0119921. PubMed ID: 34494876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ganoderma microsporum immunomodulatory protein acts as a multifunctional broad-spectrum antiviral against SARS-CoV-2 by interfering virus binding to the host cells and spike-mediated cell fusion.
    Ho HPT; Vo DNK; Lin TY; Hung JN; Chiu YH; Tsai MH
    Biomed Pharmacother; 2022 Nov; 155():113766. PubMed ID: 36271550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of natural compounds as SARS-CoV-2 entry inhibitors by molecular docking-based virtual screening with bio-layer interferometry.
    Zhang D; Hamdoun S; Chen R; Yang L; Ip CK; Qu Y; Li R; Jiang H; Yang Z; Chung SK; Liu L; Wong VKW
    Pharmacol Res; 2021 Oct; 172():105820. PubMed ID: 34403732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The green tea catechin epigallocatechin gallate inhibits SARS-CoV-2 infection.
    Henss L; Auste A; Schürmann C; Schmidt C; von Rhein C; Mühlebach MD; Schnierle BS
    J Gen Virol; 2021 Apr; 102(4):. PubMed ID: 33830908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Photoactivable Natural Product with Broad Antiviral Activity against Enveloped Viruses, Including Highly Pathogenic Coronaviruses.
    Meunier T; Desmarets L; Bordage S; Bamba M; Hervouet K; Rouillé Y; François N; Decossas M; Sencio V; Trottein F; Tra Bi FH; Lambert O; Dubuisson J; Belouzard S; Sahpaz S; Séron K
    Antimicrob Agents Chemother; 2022 Feb; 66(2):e0158121. PubMed ID: 34807755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A molecularly engineered, broad-spectrum anti-coronavirus lectin inhibits SARS-CoV-2 and MERS-CoV infection in vivo.
    Chan JF; Oh YJ; Yuan S; Chu H; Yeung ML; Canena D; Chan CC; Poon VK; Chan CC; Zhang AJ; Cai JP; Ye ZW; Wen L; Yuen TT; Chik KK; Shuai H; Wang Y; Hou Y; Luo C; Chan WM; Qin Z; Sit KY; Au WK; Legendre M; Zhu R; Hain L; Seferovic H; Tampé R; To KK; Chan KH; Thomas DG; Klausberger M; Xu C; Moon JJ; Stadlmann J; Penninger JM; Oostenbrink C; Hinterdorfer P; Yuen KY; Markovitz DM
    Cell Rep Med; 2022 Oct; 3(10):100774. PubMed ID: 36195094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection.
    Khare P; Sahu U; Pandey SC; Samant M
    Virus Res; 2020 Dec; 290():198169. PubMed ID: 32979476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
    Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.